. Author manuscript; available in PMC: 2017 Jun 1.

Published in final edited form as: Am J Clin Oncol. 2016 Jun;39(3):223–227. doi: 10.1097/COC.0000000000000044

Table 1.

Patients Characteristics

	Total : 88 thymoma patients

Mean Age	57

Men: Women (No., %)	42: 46 (49%: 52%)

Associated Myasthenia Gravis (No., %)	26 (30%)

Stage I (No., %)	33 (37.5%)

Stage II (No., %)	22 (25%)

Stage III (No., %)	18 (20.5)

Stage IV (No., %)	15 (17%)

Margin positive patients (No., %)	37 (42%)

Recurrence (No., %)	20 (22.7%)

Mortality from the disease (No., %)	13 (15%)

Stage I patients who received both S & RT	2 (6.2% of 33 stage I patients)

Stage II patients who received both S & RT	9 (40.9% of 22 stage I patients)

Stage III patients who received both S & RT	13 (72.2% of 18 stage I patients)

Stage IV patients who received both S & RT	7 (46.7% of 15 stage I patients)